SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-362750
Filing Date
2013-09-10
Accepted
2013-09-10 16:06:36
Documents
4
Period of Report
2013-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d595990d8k.htm 8-K 26410
2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION d595990dex31.htm EX-3.1 40078
3 SUPPLY AND LICENSE AGREEMENT d595990dex101.htm EX-10.1 464873
4 PRESS RELEASE d595990dex991.htm EX-99.1 12151
  Complete submission text file 0001193125-13-362750.txt   544930
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 131088193
SIC: 8731 Services-Commercial Physical & Biological Research